Lineage Cell Therapeutics
LCTX
#8976
Rank
โ‚ฌ90.07 M
Marketcap
0,39ย โ‚ฌ
Share price
3.62%
Change (1 day)
-70.32%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -โ‚ฌ19.99 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ9.49 Million. , an increase over its 2023 earnings that were of -โ‚ฌ22.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ19.6 Million-13.16%
2023 -โ‚ฌ22.57 Million9.83%
2022 -โ‚ฌ20.55 Million-54.24%
2021 -โ‚ฌ44.9 Million86.07%
2020 -โ‚ฌ24.13 Million-31.97%
2019 -โ‚ฌ35.47 Million-5.42%
2018 -โ‚ฌ37.5 Million1.1%
2017 -โ‚ฌ37.09 Million-31.06%
2016 -โ‚ฌ53.8 Million-10.38%
2015 -โ‚ฌ60.03 Million29.69%
2014 -โ‚ฌ46.29 Million31.68%
2013 -โ‚ฌ35.15 Million
2011 -โ‚ฌ17.06 Million89.78%
2010 -โ‚ฌ8.99 Million206.06%
2009 -โ‚ฌ2.94 Million-0.58%
2008 -โ‚ฌ2.96 Million164.89%
2007 -โ‚ฌ1.12 Million-30.22%
2006 -โ‚ฌ1.6 Million
2002 -โ‚ฌ1.86 Million-41.04%
2001 -โ‚ฌ3.15 Million-32.04%
2000 -โ‚ฌ4.64 Million-11.85%
1999 -โ‚ฌ5.26 Million
1997 -โ‚ฌ3.38 Million12.12%
1996 -โ‚ฌ3.02 Million106.25%
1995 -โ‚ฌ1.46 Million-11.11%
1994 -โ‚ฌ1.65 Million50%
1993 -โ‚ฌ1.1 Million20%
1992 -โ‚ฌ0.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.14 Billion 565.31%๐Ÿ‡บ๐Ÿ‡ธ USA